O’Melveny represented TYK Medicines in the transaction. TYK Medicines, Inc. (2410.HK) executed its initial public offering and listing on the Main Board of the Hong Kong...
You must be a Standard 1 Year member to access this content.
Ashurst acted as the U.S. counsel to Shanghai Voicecomm Information Technology, while O’Melveny represented the underwriters on the offering. Shanghai Voicecomm Information Technology Co., Ltd. (2495.HK)...
You must be a Standard 1 Year member to access this content.
Cooley advised the joint sponsors and underwriters on the deal while O’Melveny represented Cryofocus Medtech (Shanghai) Co., Ltd. Cryofocus Medtech announced its HK$210 million ($27 million) initial...
You must be a Standard 1 Year member to access this content.
O’Melveny advised the sponsors and underwriters on the listing, while Wilson Sonsini Goodrich & Rosati and Maples and Calder represented Huafang. Huafang Group Inc. announced the IPO...
You must be a Standard 1 Year member to access this content.
O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
You must be a Standard 1 Year member to access this content.
O’Melveny represented China International Capital Corporation Hong Kong Securities Limited (CICC) and China Industrial Securities International Capital Limited on the deal. China International Capital Corporation Hong...
You must be a Standard 1 Year member to access this content.
